2024 Global Life Sciences Deal Terms & Royalty Rate Survey Event

Please join the Licensing Executives Society San Diego Chapter for our next event (members and non-members welcome)! Our speaker will present a summary of the findings and value of the 2024 Life Sciences Global Royalty Rate surveys. The 2024 Life Science survey follows a decade of prior surveys, revealing trends in dealmaking, including valuation by technology type and stage of development, detailed consideration of royalty components, milestones, sources, and more. The LES Global Royalty Rate surveys provide exceptional detail not found in other resources.

Special points of interest in Life Science include:

Speaker
Adam Lenain, Mintz

Adam routinely assists public and private life sciences and technology companies and their investors navigate complex legal and business issues throughout the corporate life cycle.  With a practical and creative focus on his clients’ intended business results, he often functions as an outside general counsel and is regularly consulted by management teams for guidance on strategic matters. 

Adam has over twenty years of experience representing clients in seed stage and venture capital financings, public offerings, reverse mergers, PIPEs, mergers and acquisitions, SEC Compliance, and complex commercial transactions.  He regularly represents both buyers and sellers in mergers and acquisitions as well as corporations and limited liability companies with respect to financings and general corporate issues that arise throughout the corporate life cycle–from formation to exit.

This event is FREE to members and non-members
Light bites and drinks provided